ACET
Adicet Bio, Inc.NASDAQHealthcare$6.99-1.29%ClosedMarket Cap: $67.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.30
P/S
0.00
EV/EBITDA
-0.36
DCF Value
$2.93
FCF Yield
-146.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-83.0%
ROA
-60.7%
ROIC
-70.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-31.9M | $-30.5M | $-2.94 | — |
| FY 2025 | $0.00 | -Infinity% | $-122.1M | $-116.8M | $-16.95 | — |
| Q3 2025 | $0.00 | NaN% | $-28.0M | $-26.9M | $-4.64 | — |
| Q2 2025 | $0.00 | NaN% | $-32.4M | $-31.2M | $-5.44 | — |
| Q1 2025 | $0.00 | NaN% | $-29.9M | $-28.2M | $-4.96 | — |
| Q4 2024 | $0.00 | NaN% | $-30.7M | $-28.7M | $-5.12 | — |
| FY 2024 | $0.00 | NaN% | $-127.6M | $-117.1M | $-21.28 | — |
| Q3 2024 | $0.00 | NaN% | $-33.2M | $-30.5M | $-5.44 | — |
| Q2 2024 | $0.00 | NaN% | $-32.8M | $-29.9M | $-5.28 | — |
| Q1 2024 | $0.00 | -Infinity% | $-30.9M | $-28.0M | $-5.60 | — |
| Q4 2023 | $0.00 | NaN% | $-31.6M | $-29.5M | $-11.04 | — |
| FY 2023 | $0.00 | NaN% | $-152.0M | $-142.7M | $-52.96 | — |